The first phase I study of a novel ultrasound contrast agent (BR14): assessment of safety and efficacy in liver and kidneys.
Department of Radiology, University of Chieti, Italy.
Raffaella
R
Basilico
Martin J K
MJ
Blomley
David O
DO
Cosgrove
Jean-Bernard
JB
Liull
Anne
A
Broillet
Albrecht
A
Bauer
Lorenzo
L
Bonomo
D000328:Adult; D003287:Contrast Media / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005466:Fluorocarbons / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D007668:Kidney / Q000000981:diagnostic imaging*; D008099:Liver / Q000000981:diagnostic imaging*; D008297:Male; D008863:Microspheres; D010743:Phospholipids / Q000008:administration & dosage*; D014463:Ultrasonography
C471302:BR14 contrast agent; D003287:Contrast Media; D005466:Fluorocarbons; D010743:Phospholipids; C108042:perfluorobutane